Skip to main content
SpringerLink
Log in

Human Malignant Glioma Therapy Using Anti-αVβ3 Integrin Agents

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Glioblastoma multiforme (GBM) is the most frequent malignant brain tumor in adults and is invariably fatal. We have investigated the effect of cyclo-(Arg-Gly-Asp-D-Phe-Val) (cRGDfV) peptide on survival of human malignant glioma cells in vitro and in vivo. Immunofluorescent analyses revealed the presence of αVβ3 integrin on U-87MG and U-373MG cells, but minimal expression on U-251MG cells. Treatment of U-87MG and U-373MG cells in vitro with cRGDfV (20 µg/ml), but not the linear peptide, resulted in the appearance of rounded and loosely attached cells with subsequent cell death. By comparison, neither this cyclic peptide nor its linear homolog had any significant effect on growth and morphology of U-251MG cells. The death of cRGDfV-treated (20 µg/ml) glioma cells was blocked by pretreatment (10 µM) of cells with DEVD-FMK and LEHD-FMK, inhibitors of caspase-3 and caspase-9, respectively. Moreover, when glioma cells grown as spheroids were treated with cRGDfV (50 µg/ml), spheroid formation was markedly reduced. Further, treatment of intracranial U-87MG tumors in scid mice with cyclic peptide significantly (p<0.001) prolonged their survival. These results indicated (i) that cRGDfV induced apoptosis of human glioma cells by binding αVβ3 integrin expressed on their cell surfaces and (ii) that cRGDfV may be an effective and non-toxic direct anti-tumor therapy for αVβ3-expressing GBMs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Cavenee WK, Bigner DD, Newcomb EW, Paulus W, Kleihues P: Diffuse astrocytomas. In: Kleihues P, Cavenee WK (eds). Pathology and Genetics of Tumours of the Nervous System. IARC Press, Lyon, France, 1997, pp 2-9

    Google Scholar 

  2. Mahaley MS, Jr, Mettlin C, Natarajan N, Laws ER, Peace BB: National survey of patterns of care for brain-tumor patients. J Neurosurg 71: 826-836, 1989

    Google Scholar 

  3. Walker MD, Green SB, Byar DP, Alexander E, Jr, Balzdorf U, Brooks WH, Hunt WE, MacCarty CS, Mahaley MS, Jr, Mealey J, Jr, Owens G, Ransohoff JI, Robertson JT, Shapiro WR, Smith KR, Jr, Wilson CB, Strike TA: Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 303: 1323-1329, 1980

    Google Scholar 

  4. Brooks PC, Montgomery AMP, Rosenfeld M, Reisfeld RA, Hu T, Klier G, Cheresh DA: Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79: 1157-1164, 1994

    Google Scholar 

  5. Brooks PC, Clark RAF, Cheresh DA: Requirement of vascular integrin αvβ3for angiogenesis. Science 264: 569-571, 1994

    Google Scholar 

  6. Ruegg C, Yilmaz A, Bieler G, Bamat J, Chaubert P, Lejeune FJ: Evidence for the involvement of endothelial cell integrin αvβ3 in the disruption of the tumor vasculature induced by TNF and IFN-γ. Nat Med 4: 408-414, 1998

    Google Scholar 

  7. Friedlander M, Brooks PC, Shaffer RW, Kincaid CM, Varner JA, Cheresh DA: Definition of two angiogenic pathways by distinct αvintegrins. Science 270: 1500-1502, 1995

    Google Scholar 

  8. Chothia C, Jones EY: The molecular structure of cell adhesion molecules. Annu Rev Biochem 66: 823-862, 1997

    Google Scholar 

  9. Ruoslahti E: RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol 12: 697-715, 1996

    Google Scholar 

  10. Felding-Habermann B, Cheresh DA: Vitronectin and its receptors. Curr Opin Cell Biol 5: 864-868, 1993

    Google Scholar 

  11. Chatterjee S, Bradac J, Hunter E: Effect of monensin on Mason-Pfizer monkey virus glycoprotein synthesis. J Virol 44: 1003-1012, 1982

    Google Scholar 

  12. Chambers R, Gillespie GY, Soroceanu L, Andreansky S, Chatterjee S, Chou J, Roizman B, Whitley RJ: Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a scid mouse model of human malignant glioma. Proc Natl Acad Sci USA, 92: 1411-1415, 1995

    Google Scholar 

  13. Salvesen GS, Dixit VM: Caspases: intracellular signaling by proteolysis. Cell 91: 443-446, 1997

    Google Scholar 

  14. Cohen GM: Caspases: the executioners of apoptosis. Biochem J 326: 1-16, 1997

    Google Scholar 

  15. Janicke RU, Sprengart ML, Wati MR, Porter AG: Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem 273: 9357-9360, 1998

    Google Scholar 

  16. Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, Frisch S, Reed JC: Regulation of cell death protease caspase-9 by phosphorylation. Science 282: 1318-1321, 1998

    Google Scholar 

  17. Sakahira H, Enari M, Nagata S: Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 391: 96-99, 1998

    Google Scholar 

  18. Gladson CL, Cheresh DA: Glioblastoma expression of vitronectin and the αvβ3 integrin: adhesion mechanism for transformed glial cells. J Clin Invest 88: 1924-1932, 1991

    Google Scholar 

  19. Gladson C, Wilcox JN, Sanders L, Gillespie GY, Cheresh DA: Cerebral microenvironment influences expression of the vitronectin gene in astrocytic tumors. J Cell Science 108: 947-956, 1995

    Google Scholar 

  20. Wikstrand CJ, Bigner SH, Bigner DD: Demonstration of complex antigenic heterogenecity in a human glioma cell line and eight derived clones by specific monoclonal antibodies. Cancer Res 43: 3327-3334, 1983

    Google Scholar 

  21. Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG: Specific proteolytic cleavage of poly (ADP-Ribose) polymerase: an early marker of chemotherapyinduced apoptosis. Cancer Res 53: 3976-3985, 1993

    Google Scholar 

  22. Satoh MS, Lindahl T: Role of poly (ADP-Ribose) formation in DNA repair. Nature 356: 356-358, 1992

    Google Scholar 

  23. Zou H, Henzel WJ, Liu X, Lutschg A, Wang X: Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90: 405-413, 1997

    Google Scholar 

  24. Stromblad S, Becker J, Yerba M, Brooks P, Cheresh D: Suppression of p53 activity and p21 expression by vascular cell integrin αvβ3 during angiogenesis. J Clin Invest 98: 426-433, 1996

    Google Scholar 

  25. Gomez-Manzano C, Fueyo J, Kyritis AP, McDonnell TJ, Steck PA, Levin VA, Yung W: Characterization of p53 and p21 functional interactions in glioma cells en route to apoptosis. J Natl Cancer Inst 89: 1036-1044, 1997

    Google Scholar 

  26. Vuori K, Ruoslahti E: Association of insulin receptor substrate-1 with integrins. Science 266: 1576-1578, 1994

    Google Scholar 

  27. Schneller M, Vuori K, Ruoslahti E: αvβ3 integrin associates with activated insulin and PDGF-? receptors and potentiates the biological activity of PDGF. EMBO J 16: 5600-5607, 1997

    Google Scholar 

  28. Nister M, Clasesson-Welch L, Enksson A, Heldin CH, Westermark B: Differential expression of platelet-derived growth factor receptors in human malignant glioma cell lines. J Biol Chem 266: 16755-16763, 1991

    Google Scholar 

  29. Glick RP, Unterman TG, Hollis R: Radioimmunoassay of insulin-like growth factors in cyst fluid of central nervous system tumors. J Neurosurg 74: 972-978, 1991

    Google Scholar 

  30. Rubin R, Baserga R: Insulin-like growth factor-I receptor: its role in cell proliferation, apoptosis and tumorigenicity. Lab Invest 73: 311-331, 1995

    Google Scholar 

  31. Yang B-C, Chang H-M, Wang Y-S, Chen R-F, Lin S-J: Transient induction of apoptosis in serum-starved glioma cells by insulin and IGF-I. Biochim Biophys Acta 1314: 83-92, 1996

    Google Scholar 

  32. Burgaud JL, Resnicoff M, Baserga R: Mutant IGF-I receptors as dominant negatives for growth and transformation. Biochem Biophys Res Commun 214: 475-481, 1995

    Google Scholar 

  33. Resnicoff M, Li W, Basak S, Herlyn D, Baserga R, Rubin R: Inhibition of rat C6 glioblastoma tumor growth by expression of insulin-like growth factor I receptor antisense mRNA. Cancer Immunol Immunother 42: 64-68, 1996

    Google Scholar 

  34. Kulik G, Kippel A, Weber MJ: Antiapoptotic signaling by the insulin-like growth factor-I receptor, phosphatidylinositol 3-kinase and Akt. Mol Cell Biol 17: 1595-1606, 1997

    Google Scholar 

  35. Saitoh Y, Kurastsu J, Takeshima H, Yamamoto S, Ushio Y: Expression of osteopontin in human gliomas: its correlation with malignancy. Lab Invest 72: 55-63, 1995

    Google Scholar 

  36. Tucker MA, Chang P, Prince CW, Gillespie GY, Mapstone TB: TPA-mediated regulation of osteopontin in human malignant glioma cells. Anticancer Res 18: 807-812, 1998

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. JCR Biopharmaceuticals, Inc., San Diego, CA, USA

    Subhendra Chatterjee & Jaime Schradermeier

  2. JCR Pharmaceuticals Co., Ltd., Ashiya, Japan

    Akiko Matsumura

  3. ivision of Neurosurgery, Brain Tumor Research Laboratories, University of Alabama at Birmingham, Birmingham, AL, USA

    G. Yancey Gillespie

Authors
  1. Subhendra Chatterjee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Akiko Matsumura
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jaime Schradermeier
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. Yancey Gillespie
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chatterjee, S., Matsumura, A., Schradermeier, J. et al. Human Malignant Glioma Therapy Using Anti-αVβ3 Integrin Agents. J Neurooncol 46, 135–144 (2000). https://doi.org/10.1023/A:1006444300504

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006444300504

Search

Navigation